These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 10915003

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Coincidence of multiple endocrine neoplasia types 1 and 2: mutations in the RET protooncogene and MEN1 tumor suppressor gene in a family presenting with recurrent primary hyperparathyroidism.
    Frank-Raue K, Rondot S, Hoeppner W, Goretzki P, Raue F, Meng W.
    J Clin Endocrinol Metab; 2005 Jul; 90(7):4063-7. PubMed ID: 15870131
    [Abstract] [Full Text] [Related]

  • 5. Multiple endocrine neoplasia type 2-associated RET proto-oncogene mutations do not contribute to the pathogenesis of sporadic parathyroid tumors.
    Willeke F, Hauer MP, Buchcik R, Gebert JF, Hahn M, Fitze G, Mechtersheimer G, Möller P, Saeger HD, Herfarth C, Schackert HK.
    Surgery; 1998 Sep; 124(3):484-90. PubMed ID: 9736899
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas.
    Komminoth P, Kunz EK, Matias-Guiu X, Hiort O, Christiansen G, Colomer A, Roth J, Heitz PU.
    Cancer; 1995 Aug 01; 76(3):479-89. PubMed ID: 8625130
    [Abstract] [Full Text] [Related]

  • 13. Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumors.
    Marsh DJ, Zheng Z, Arnold A, Andrew SD, Learoyd D, Frilling A, Komminoth P, Neumann HP, Ponder BA, Rollins BJ, Shapiro GI, Robinson BG, Mulligan LM, Eng C.
    J Clin Endocrinol Metab; 1997 Sep 01; 82(9):3025-8. PubMed ID: 9284737
    [Abstract] [Full Text] [Related]

  • 14. Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and hirschsprung disease.
    Eng C, Mulligan LM.
    Hum Mutat; 1997 Sep 01; 9(2):97-109. PubMed ID: 9067749
    [Abstract] [Full Text] [Related]

  • 15. RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.
    Marsh DJ, Mulligan LM, Eng C.
    Horm Res; 1997 Sep 01; 47(4-6):168-78. PubMed ID: 9167949
    [Abstract] [Full Text] [Related]

  • 16. Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation.
    Kawai K, Iwashita T, Murakami H, Hiraiwa N, Yoshiki A, Kusakabe M, Ono K, Iida K, Nakayama A, Takahashi M.
    Cancer Res; 2000 Sep 15; 60(18):5254-60. PubMed ID: 11016655
    [Abstract] [Full Text] [Related]

  • 17. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
    Marx SJ, Agarwal SK, Kester MB, Heppner C, Kim YS, Skarulis MC, James LA, Goldsmith PK, Saggar SK, Park SY, Spiegel AM, Burns AL, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Emmert-Buck MR, Guru SC, Manickam P, Crabtree J, Erdos MR, Collins FS, Chandrasekharappa SC.
    Recent Prog Horm Res; 1999 Sep 15; 54():397-438; discussion 438-9. PubMed ID: 10548885
    [Abstract] [Full Text] [Related]

  • 18. Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s.
    Zedenius J, Wallin G, Hamberger B, Nordenskjöld M, Weber G, Larsson C.
    Hum Mol Genet; 1994 Aug 15; 3(8):1259-62. PubMed ID: 7987299
    [Abstract] [Full Text] [Related]

  • 19. Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma.
    Eng C, Mulligan LM, Smith DP, Healey CS, Frilling A, Raue F, Neumann HP, Ponder MA, Ponder BA.
    Clin Endocrinol (Oxf); 1995 Jul 15; 43(1):123-7. PubMed ID: 7641404
    [Abstract] [Full Text] [Related]

  • 20. Genetic defects associated with familial and sporadic hyperparathyroidism.
    Hendy GN, Cole DE.
    Front Horm Res; 2013 Jul 15; 41():149-65. PubMed ID: 23652676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.